Default object view. Click to create a custom template, Node ID: 135934, Object ID: 79964

A phase II trial of abiraterone acetate plus prednisone in patients with triple-negative androgen receptor positive locally advanced or metastatic...

A phase II trial of abiraterone acetate plus prednisone in patients with triple-negative androgen receptor positive locally advanced or metastatic breast cancer (UCBG 12-1)

Tags: Locally advanced Locally advanced , Metastatic Metastatic

No relation

Yes

No relation

No

18/02/2016 3:08 pm

No